Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Profile neighbors
ZMYM6 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RGP1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
POC1A - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
MOSPD1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ANXA11 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
USP38 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ANXA13 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
PNKP - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
VRK3 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ITPRIPL2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
ATG101 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
DUSP4 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
GTPBP1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
EFHD2 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
SMCHD1 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
CAB39 - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
IL17RE - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
TDG - Highly Active Antiretroviral Therapy (HAART) interruption effect on HIV patients: jejunal mucosa
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on